bpc 157 peptide risk BPC-157: Miracle Healing or Hidden Danger? BPC-157 | Peak Biosciences

Manufacturer: Pfizer

No Membership Fees There are no membership fees with UrWay Health

Passive diffusion accounts for 1.2% of overall absorption, with little effect on bioavailability in patients with pernicious anemia or gastro-duodenal resection [49, 50]

Despite these promising findings, it is critical to evaluate safety, as there is a significant lack of comprehensive clinical trials to establish the safety or efficacy of BPC-157 in humans

Side effects are generally mild most often injection site irritation, fatigue, or headache

Dosing information Usual Adult Dose for Pernicious Anemia: Initial dose: 100 mcg intramuscularly or deep subcutaneous once a day for 6 to 7 days If clinical improvement and reticulocyte response is seen from the above dosing: 100 mcg every other day for 7 doses, then: 100 mcg every 3 to 4 days for 2 to 3 weeks, then: Maintenance dose: 100 to 1000 mcg monthly Duration of therapy: Life Comments: Administer concomitant folic acid if needed